ALLIQUA BIOMEDICAL INC - COM NEW (ALQA)

CUSIP: 019621200

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM NEW
Total 13F shares
8,850,490
Share change
+58,513
Total reported value
$7,006,000
Price per share
$0.79
Number of holders
27
Value change
+$35,766
Number of buys
9
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 019621200?
CUSIP 019621200 identifies ALQA - ALLIQUA BIOMEDICAL INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) as of Q3 2016

As of 30 Sep 2016, ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,850,490 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Tekla Capital Management LLC, SABBY MANAGEMENT, LLC, SUFFOLK CAPITAL MANAGEMENT LLC, PURA VIDA INVESTMENTS, LLC, J. Goldman & Co LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, US BANCORP \DE\, and AMERIPRISE FINANCIAL INC. This page lists 27 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.